Cwm LLC Raises Stock Holdings in Waters Co. (NYSE:WAT)

Cwm LLC raised its position in shares of Waters Co. (NYSE:WAT) by 9.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,181 shares of the medical instruments supplier’s stock after buying an additional 99 shares during the quarter. Cwm LLC’s holdings in Waters were worth $425,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of WAT. Linscomb Wealth Inc. lifted its position in Waters by 0.4% during the 2nd quarter. Linscomb Wealth Inc. now owns 7,841 shares of the medical instruments supplier’s stock valued at $2,275,000 after acquiring an additional 34 shares during the period. Johnson Investment Counsel Inc. lifted its holdings in shares of Waters by 3.2% during the second quarter. Johnson Investment Counsel Inc. now owns 1,084 shares of the medical instruments supplier’s stock valued at $314,000 after purchasing an additional 34 shares during the last quarter. Summit Trail Advisors LLC lifted its holdings in shares of Waters by 3.0% during the second quarter. Summit Trail Advisors LLC now owns 1,170 shares of the medical instruments supplier’s stock valued at $339,000 after purchasing an additional 34 shares during the last quarter. Retirement Systems of Alabama grew its stake in shares of Waters by 0.3% in the 2nd quarter. Retirement Systems of Alabama now owns 13,087 shares of the medical instruments supplier’s stock worth $3,797,000 after buying an additional 37 shares during the last quarter. Finally, Argent Trust Co increased its position in Waters by 4.3% during the 2nd quarter. Argent Trust Co now owns 1,010 shares of the medical instruments supplier’s stock valued at $293,000 after buying an additional 42 shares in the last quarter. Institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Deutsche Bank Aktiengesellschaft dropped their target price on Waters from $330.00 to $310.00 and set a “hold” rating on the stock in a report on Thursday, August 1st. The Goldman Sachs Group upgraded shares of Waters to a “hold” rating in a research note on Wednesday, July 31st. Evercore ISI increased their price objective on shares of Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Cfra set a $389.00 target price on shares of Waters in a report on Thursday. Finally, Leerink Partnrs upgraded shares of Waters from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 1st. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Waters currently has a consensus rating of “Hold” and an average price target of $342.58.

Waters Stock Performance

Shares of WAT opened at $348.45 on Monday. The firm has a market capitalization of $20.68 billion, a P/E ratio of 34.71, a PEG ratio of 6.85 and a beta of 0.95. The company has a debt-to-equity ratio of 1.42, a current ratio of 2.10 and a quick ratio of 1.42. Waters Co. has a one year low of $231.90 and a one year high of $367.21. The business has a fifty day moving average of $342.54 and a 200 day moving average of $325.07.

Waters (NYSE:WAT) last released its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $2.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.55 by $0.08. Waters had a return on equity of 56.81% and a net margin of 20.71%. The business had revenue of $709.00 million during the quarter, compared to the consensus estimate of $700.09 million. During the same period in the previous year, the company posted $2.80 EPS. The business’s quarterly revenue was down 4.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that Waters Co. will post 11.6 EPS for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.